corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 13660

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Pfizer to disclose grants to increase transparency
Pharma Times 2008 May 15
http://www.pharmatimes.com/WorldNews/article.aspx?id=13496&src=EWorldNews


Full text:

A day after Eli Lilly stated its support for the revised Physician Payments Sunshine Act about declaring gifts to doctors, Pfizer has announced that it is posting a list of grants and charitable contributions made in the first quarter.

The New York-based drugs giant says that the move, which follows a similar policy adopted by Lilly last year, is “part of an ongoing drive throughout the company to increase transparency”. Of $9.97 million given out to 242 US medical, scientific and patient organisations in the first quarter of 2008, the largest grant, one of over $3.4 million, was made to the California Academy of Family Physicians in March for “ a three-year national health care professional education campaign to reduce the number of US smokers”. Pfizer markets the smoking cessation treatment Chantix (varenicline).

Chief executive Jeff Kindler said that “detailing these grants and charitable contributions is an important part of our ongoing transparency drive.” Pfizer also noted that it began disclosing political contributions and registering clinical trials in 2002 and in 2006 launched a regularly updated public site describing compounds under development and their progress. Last year, it began reporting its post-marketing commitments to the US Food and Drug Administration relating to the safety, efficacy or the use of its medicines.

The issue of transparency is under the spotlight again with the updated version of Sunshine Act which is due to come into force at the end of March 2011. Lilly has backed the changes which raises the payment limit requiring disclosure from $25 to $500, while possible fines have been reduced to $1,000-$50,000 from $10,000-$100,000 for each violation.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.